Skip to NavigationSkip to content


Transactions in the pharma sector: Through the EU merger review looking-glass

Published on 09/12/19 at 10:20am

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) of global law firm Dechert review and evaluate investigations of M&A activity to determine what this reveals about the industry as it moves forward.

“At least I know who I was when I got up this morning, but I think I must have been changed several times since then.” – Lewis Carroll, Alice in Wonderland

Patient experience: Living with desmoid fibromatosis

Published on 04/12/19 at 12:51pm

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis and experience with the UK healthcare system, as well as her advocacy for Desmoid United UK and her proactive approach to change things for the better.

Can you explain a bit about your condition?

The coming age of biosimilars

Published on 25/11/19 at 03:58pm

With more and more biosimilars securing approval and the sheer potential value they have to offer for healthcare systems around the world, Nikhil Patel takes a look at the current market landscape and how things could be shifting for the better.

Bringing the clinical trial home

Published on 18/11/19 at 01:07pm

Clinical trials are the backbone of healthcare and drug research, but many key patient populations have in the past been unable to take part in these trials because of their traditional format. Fortunately, technology has risen to the challenges of modern research and provided a solution, as Matt Fellows discovers.

Working Life Interview: Alison Muir, Oncology Product Strategy Director at Roche

Published on 11/11/19 at 01:03pm

You studied biology at Liverpool John Moores University before heading straight to GSK in 1990 as a Sales Representative; was a career in pharma always the plan?

No it wasn’t. I studied biology at John Moores, specialising in plant Pathology, so I was initially interested in horticulture. I’d grown up in a farming community, so I quickly worked out, after a placement year working for the Ministry of Agriculture, that the part I really loved was going out and engaging with the farmers, setting up trials in their fields, and working with the community.

Breaking through limits in lung cancer: Introducing the Lung Ambition Alliance

Published on 07/10/19 at 11:34am

Lung cancer kills more patients than any other variety of cancer, accounting for around a fifth of all cancer-related deaths worldwide. In 2018 alone, the disease claimed 1.8 million lives around the globe – that’s a life lost every 18 seconds. A huge factor in these high mortality rates is timely diagnosis, or lack thereof; currently, 40% of patients are diagnosed when their cancer has already metastasised and spread beyond the lungs to other parts of the body, negatively impacting their prognosis.

The world needs a better plan for cancer survival by 2030

Published on 30/09/19 at 11:22am

Beginning on 24 September, the UN will convene in New York for its annual General Assermbly. Dr Christian Rommel, Roche´s Global Head of Pharma Research & Early Development (pRED) Oncology, discusses the event’s ambitious call to arms to “build a healthier world”, and the transformative and uncompromising path that will need to be laid ahead in order to make that a reality over the next decade.

Living with acute myeloid leukaemia

Published on 23/09/19 at 11:48am

Steve Rothberg was blindsided by an AML diagnosis that progressed rapidly with little warning. Ten years later, he discusses his outlook and strategies during the intensive treatment, and how a coincidental GP visit and a stem cell transplant changed the course of what might have been.

What originally alerted you to the fact that something was off with your physical health?

Working Life: Linda Armstrong, Global Head, Respiratory Development Unit at Novartis

Published on 27/08/19 at 12:16pm

Linda Armstrong, Global Head, Respiratory Development Unit at Novartis.

Making things personal: Roche and personalised medicine

Published on 13/08/19 at 11:42am

Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to patient care to tackle today’s health challenges, and how big data and the interplay between pharmaceuticals and diagnostics are key to driving progress in this area.

Can you explain the core idea behind personalised medicine and why it is increasingly gathering traction?

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches